Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 50S ribosomal subunit is the larger component of the prokaryotic 70S ribosome, playing a critical role in protein biosynthesis (Wilson, D. N., 2014, Nature Reviews Microbiology). It contains the peptidyl transferase center (PTC), which catalyzes the formation of peptide bonds between amino acids, and the exit tunnel through which the growing polypeptide chain leaves the ribosome (Polikanov et al., 2012, Molecular Cell). Because of its essential role in bacterial survival and its structural differences from the eukaryotic 60S subunit, it is a primary target for several classes of antibiotics, including macrolides, lincosamides, and oxazolidinones (Dunkle et al., 2010, Science). These drugs typically bind to the 23S rRNA within the subunit to disrupt translation, effectively halting bacterial growth or causing cell death (StatPearls, 2023). However, the similarity between bacterial ribosomes and human mitochondrial ribosomes can lead to off-target effects and toxicity during prolonged treatment (Erakovic et al., 2020, Antibiotics). Understanding the structural nuances of the 50S subunit is vital for overcoming emerging antibiotic resistance mechanisms, such as ribosomal methylation or mutations in the binding sites (Vester & Douthwaite, 2001, Antimicrobial Agents and Chemotherapy).
Inhibition of bacterial protein synthesis by binding to the 23S rRNA of the 50S subunit, which interferes with peptidyl transferase activity, inhibits the translocation of the peptidyl-tRNA, or physically blocks the exit of the nascent polypeptide chain (StatPearls, 2023; Wilson, 2014).
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit (50S) (50S).